Clinical trial
Clinical Trial to Assess the Effects of Candesartan on the Carbohydrate…
NCT00319202 · Fundación Cardiovascular de Colombia, Other · Terminated
Key facts
| NCT number | NCT00319202 |
|---|---|
| Title | Clinical Trial to Assess the Effects of Candesartan on the Carbohydrate Metabolism of Obese Subjects |
| Official title | A Randomized, Double Blind, Cross-Over, Placebo-Controlled Clinical Trial to Assess the Effects of Candesartan on the Carbohydrate Metabolism, of Non Diabetic, Non Hypertensive Subjects With Dysglycemia and Abdominal Obesity."ARAMIA" |
| Acronym | ARAMIA |
| Lead sponsor | Fundación Cardiovascular de Colombia, Other |
| Collaborators | AstraZeneca Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Glucose Intolerance, Obesity |
| Intervention type | Drug |
| Interventions | Candesartan, Placebo |
| Enrollment | 56 |
| Start date | Jun 1, 2006 |
| Primary completion | Feb 1, 2010 |
| Completion | Feb 1, 2012 |
| First posted | Apr 27, 2006 |
| Last update posted | Nov 6, 2012 |
| Countries | Colombia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: